Identification of multiple mechanisms of resistance to vemurafenib in a patient with BRAFV600E-mutated cutaneous melanoma successfully rechallenged after progression.
Romano E et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research, 2013